This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.38 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract.
Generated 3/23/25, 12:55 AM